Chung HJ - Search Results

1

Hypertrichosis lanuginosa acquisita associated with autoimmune hepatitis.

Roh MR, Chung HJ, Cho YH, Chung KY. Roh MR, et al. Among authors: chung ky, chung hj. J Dermatol. 2006 Aug;33(8):574-6. doi: 10.1111/j.1346-8138.2006.00124.x. J Dermatol. 2006. PMID: 16923142

2

A case of acute hemorrhagic edema of infancy.

Roh MR, Chung HJ, Lee JH. Roh MR, et al. Among authors: chung hj. Yonsei Med J. 2004 Jun 30;45(3):523-6. doi: 10.3349/ymj.2004.45.3.523. Yonsei Med J. 2004. PMID: 15227741 Free article.

3

Pharmacokinetic changes of ipriflavone in rats with acute renal failure induced by uranyl nitrate.

Chung HJ, Lee MG. Chung HJ, et al. Biopharm Drug Dispos. 2006 Oct;27(7):345-51. doi: 10.1002/bdd.515. Biopharm Drug Dispos. 2006. PMID: 16902944

4

Effects of water deprivation on the pharmacokinetics of theophylline and one of its metabolites, 1,3-dimethyluric acid, after intravenous and oral administration of aminophylline to rats.

Choi HD, Kang HE, Chung HJ, Bae SK, Shin KN, Lee MG. Choi HD, et al. Among authors: chung hj. Biopharm Drug Dispos. 2007 Nov;28(8):445-54. doi: 10.1002/bdd.573. Biopharm Drug Dispos. 2007. PMID: 17847127

5

Effects of E. Coli lipopolysaccharide on the pharmacokinetics of ipriflavone and its metabolites, M1 and M5, after intravenous and oral administration of ipriflavone to rats: decreased metabolism of ipriflavone due to decreased expression of hepatic CYP1A2 and 2C11.

Chung HJ, Kang HE, Bae EJ, Lee I, Kim SG, Lee MG. Chung HJ, et al. J Pharm Sci. 2008 Nov;97(11):5024-36. doi: 10.1002/jps.21343. J Pharm Sci. 2008. PMID: 18314883

6

KST5468, a new T-type calcium channel antagonist, has an antinociceptive effect on inflammatory and neuropathic pain models.

Lee MJ, Shin TJ, Lee JE, Choo H, Koh HY, Chung HJ, Pae AN, Lee SC, Kim HJ. Lee MJ, et al. Among authors: chung hj. Pharmacol Biochem Behav. 2010 Dec;97(2):198-204. doi: 10.1016/j.pbb.2010.07.018. Epub 2010 Aug 3. Pharmacol Biochem Behav. 2010. PMID: 20678515

7

Pharmacokinetics of L-FMAUS, a new antiviral agent, after intravenous and oral administration to rats: contribution of gastrointestinal first-pass effect to low bioavailability.

Chung HJ, Lee JH, Woo SJ, Park HK, Koo CH, Lee MG. Chung HJ, et al. Biopharm Drug Dispos. 2007 May;28(4):187-97. doi: 10.1002/bdd.545. Biopharm Drug Dispos. 2007. PMID: 17377948

8

Ipriflavone pharmacokinetics in mutant Nagase analbuminemic rats.

Chung HJ, Kang HE, Yang KH, Kim SY, Lee MG. Chung HJ, et al. Biopharm Drug Dispos. 2009 Sep;30(6):294-304. doi: 10.1002/bdd.667. Biopharm Drug Dispos. 2009. PMID: 19591122

9

Pharmacokinetics of DA-6034, an agent for inflammatory bowel disease, in rats and dogs: Contribution of intestinal first-pass effect to low bioavailability in rats.

Chung HJ, Choi YH, Choi HD, Jang JM, Shim HJ, Yoo M, Kwon JW, Lee MG. Chung HJ, et al. Eur J Pharm Sci. 2006 Mar;27(4):363-74. doi: 10.1016/j.ejps.2005.11.008. Epub 2006 Jan 4. Eur J Pharm Sci. 2006. PMID: 16387482

10

Effects of enzyme inducers and inhibitors on the pharmacokinetics of intravenous ipriflavone in rats.

Chung HJ, Choi YH, Kim SH, Lee MG. Chung HJ, et al. J Pharm Pharmacol. 2006 Apr;58(4):449-57. doi: 10.1211/jpp.58.4.0004. J Pharm Pharmacol. 2006. PMID: 16597362

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,069 results

Search Page

Filters